HomeTDAC • NASDAQ
add
Translational Development Acquisitin Crp
Previous close
$10.58
Year range
$10.07 - $10.58
Market cap
231.78M USD
Avg Volume
7.38K
P/E ratio
48.72
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 162.34K | 21.71% |
Net income | 1.60M | 19,939.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.79K | -93.20% |
Total assets | 181.70M | 3.83% |
Total liabilities | 188.24M | 4.23% |
Total equity | -6.54M | — |
Shares outstanding | 4.66M | — |
Price to book | -7.56 | — |
Return on assets | -0.22% | — |
Return on capital | 6.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.60M | 19,939.50% |
Cash from operations | -117.36K | 85.53% |
Cash from investing | — | — |
Cash from financing | 100.00K | -99.94% |
Net change in cash | -17.36K | -108.11% |
Free cash flow | -56.48K | 85.55% |
About
Founded
2022
